Hypertension and the Kidney: Reduced Kidney Mass Is Bad for Both Normotensive and Hypertensive Rats

Kyle Ware1, Vedat Yildiz2, Min Xiao1

  • 1Department of Pathology, The Ohio State University, Columbus, Ohio, USA.

Abstract

Insights

Hypertension exacerbates kidney injury after 5/6 nephrectomy, leading to worse outcomes in hypertensive rats. Histology reveals more severe damage than blood markers alone.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Experimental Pathology

Background:

  • Hypertension is a primary driver of chronic kidney disease globally.
  • Previous research focused on short-term hypertension effects on kidney function post-nephrectomy.
  • This study examines the long-term impact of hypertension on kidney injury in a 5/6 nephrectomy model.

Purpose of the Study:

  • To investigate the long-term consequences of hypertension in rats undergoing 5/6 nephrectomy.
  • To compare kidney injury progression in hypertensive versus normotensive rats post-nephrectomy.

Main Methods:

  • Created 5/6 nephrectomy in Spontaneous Hypertensive Rats (SHR) and Wistar Kyoto (WKY) rats.
  • Monitored blood pressure, serum creatinine, hematuria, and proteinuria weekly for 23 weeks.
  • Assessed kidney morphology at study completion; used sham-operated rats as controls.

Main Results:

  • 5/6 nephrectomy increased serum creatinine, blood pressure, hematuria, and proteinuria in both SHR and WKY rats.
  • 5/6 nephrectomy SHR showed earlier onset and higher proteinuria than WKY rats.
  • Histological analysis revealed enlarged glomeruli, interstitial fibrosis, and intimal thickening in 5/6 nephrectomy SHR compared to WKY rats.

Conclusions:

  • Long-term kidney injury severity correlated with elevated blood pressure.
  • Kidney mass reduction worsens kidney function and elevates blood pressure in both normotensive and hypertensive rats.
  • Histological assessment offers superior insight into chronic kidney injury compared to serum creatinine and urinalysis alone.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
260
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
1.9K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
955
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
158
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
1.8K